116 related articles for article (PubMed ID: 9407970)
1. Expression of sex hormone-binding globulin exon VII splicing variant messenger RNA in human uterine endometrial cancers.
Misao R; Nakanishi Y; Fujimoto J; Tamaya T
Cancer Res; 1997 Dec; 57(24):5579-83. PubMed ID: 9407970
[TBL] [Abstract][Full Text] [Related]
2. Relatively high expression ratio of sex hormone-binding globulin exon VII splicing variant to wild-type mRNA in human uterine cervical cancers.
Misao R; Nakanishi Y; Fujimoto J; Tamaya T
Jpn J Cancer Res; 1998 Jan; 89(1):47-52. PubMed ID: 9510475
[TBL] [Abstract][Full Text] [Related]
3. Expression of sex hormone-binding globulin exon VII splicing variant mRNA in human uterine endometrium.
Misao R; Fujimoto J; Nakanishi Y; Tamaya T
J Steroid Biochem Mol Biol; 1997 Aug; 62(5-6):385-90. PubMed ID: 9449241
[TBL] [Abstract][Full Text] [Related]
4. Dominant expression of sex-hormone-binding-globulin exon-7 splicing variant over wild-type mRNA in human ovarian cancers.
Misao R; Nakanishi Y; Fujimoto J; Iwagaki S; Tamaya T
Int J Cancer; 1998 Sep; 77(6):828-32. PubMed ID: 9714049
[TBL] [Abstract][Full Text] [Related]
5. Expression of sex hormone-binding globulin exon VII splicing variant mRNA in human uterine myometrium and leiomyoma.
Misao R; Nakanishi Y; Fujimoto J; Tamaya T
J Steroid Biochem Mol Biol; 1997; 63(4-6):269-74. PubMed ID: 9459193
[TBL] [Abstract][Full Text] [Related]
6. Expression of sex hormone-binding globulin exon 7 splicing variant mRNA in secondary spreading lesions of gynecological cancers.
Misao R; Iwagaki S; Fujimoto J; Nakanishi Y; Sun WS; Tamaya T
J Steroid Biochem Mol Biol; 1999 Feb; 68(3-4):103-9. PubMed ID: 10369407
[TBL] [Abstract][Full Text] [Related]
7. Expression of sex hormone-binding globulin exon VII splicing variant messenger ribonucleic acid in human ovarian endometriosis.
Misao R; Nakanishi Y; Fujimoto J; Tamaya T
Fertil Steril; 1998 Feb; 69(2):324-8. PubMed ID: 9496349
[TBL] [Abstract][Full Text] [Related]
8. Association of endometrial cancer risk with a functional polymorphism (Asp(327)Asn) in the sex hormone-binding globulin gene.
Kataoka N; Cai Q; Xu WH; Xiang YB; Cai H; Zheng W; Shu XO
Cancer; 2007 Apr; 109(7):1296-302. PubMed ID: 17315164
[TBL] [Abstract][Full Text] [Related]
9. Expression of sex hormone-binding globulin mRNA in human endometrial cancers.
Misao R; Nakanishi Y; Ichigo S; Hori M; Fujimoto J; Tamaya T
J Steroid Biochem Mol Biol; 1995 Jun; 52(6):517-22. PubMed ID: 7779755
[TBL] [Abstract][Full Text] [Related]
10. Expression of sex hormone-binding globulin (SHBG) in human granulosa-lutein cells.
Forges T; Gérard A; Hess K; Monnier-Barbarino P; Gérard H
Mol Cell Endocrinol; 2004 Apr; 219(1-2):61-8. PubMed ID: 15149727
[TBL] [Abstract][Full Text] [Related]
11. [Expression of estrogen receptor beta mRNA in endometrial carcinoma and its significance].
Wen H
Zhonghua Fu Chan Ke Za Zhi; 2001 Feb; 36(2):108-10. PubMed ID: 11783346
[TBL] [Abstract][Full Text] [Related]
12. The human sex hormone-binding globulin gene contains exons for androgen-binding protein and two other testicular messenger RNAs.
Hammond GL; Underhill DA; Rykse HM; Smith CL
Mol Endocrinol; 1989 Nov; 3(11):1869-76. PubMed ID: 2608061
[TBL] [Abstract][Full Text] [Related]
13. Variant progesterone receptor mRNAs are co-expressed with the wild-type progesterone receptor mRNA in human endometrium during all phases of the menstrual cycle.
Marshburn PB; Zhang J; Bahrani-Mostafavi Z; Matthews ML; White J; Hurst BS
Mol Hum Reprod; 2005 Nov; 11(11):809-15. PubMed ID: 16339776
[TBL] [Abstract][Full Text] [Related]
14. Conservation and expression of an alternative 3' exon of Runx2 encoding a novel proline-rich C-terminal domain.
Terry A; Kilbey A; Vaillant F; Stewart M; Jenkins A; Cameron E; Neil JC
Gene; 2004 Jul; 336(1):115-25. PubMed ID: 15225881
[TBL] [Abstract][Full Text] [Related]
15. A new subclass of the luteinizing hormone/chorionic gonadotropin receptor lacking exon 10 messenger RNA in the New World monkey (Platyrrhini) lineage.
Gromoll J; Wistuba J; Terwort N; Godmann M; Müller T; Simoni M
Biol Reprod; 2003 Jul; 69(1):75-80. PubMed ID: 12606382
[TBL] [Abstract][Full Text] [Related]
16. Expression of an estrogen receptor alpha variant protein in cell lines and tumors.
Fasco MJ; Keyomarsi K; Arcaro KF; Gierthy JF
Mol Cell Endocrinol; 2000 Aug; 166(2):156-69. PubMed ID: 11203301
[TBL] [Abstract][Full Text] [Related]
17. Loss of alternately spliced messenger RNA of the luteinizing hormone receptor and stability of the follicle-stimulating hormone receptor messenger RNA in granulosa cell tumors of the human ovary.
Reinholz MM; Zschunke MA; Roche PC
Gynecol Oncol; 2000 Nov; 79(2):264-71. PubMed ID: 11063655
[TBL] [Abstract][Full Text] [Related]
18. Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays.
Graham IR; Hill VJ; Manoharan M; Inamati GB; Dickson G
J Gene Med; 2004 Oct; 6(10):1149-58. PubMed ID: 15386737
[TBL] [Abstract][Full Text] [Related]
19. Sex steroid-dependent angiogenesis in uterine endometrial cancers.
Fujimoto J; Toyoki H; Jahan I; Alam SM; Sakaguchi H; Sato E; Tamaya T
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):161-5. PubMed ID: 15860258
[TBL] [Abstract][Full Text] [Related]
20. The influence of hormones on CD44 expression in endometrial and breast carcinomas.
Durst B; Sorg RV; Röder G; Betz B; Beckmann MW; Niederacher D; Bender HG; Dall P
Oncol Rep; 2001; 8(5):987-93. PubMed ID: 11496303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
